Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ensysce Biosciences (ENSC) Debt Ratio (2020 - 2022)

Ensysce Biosciences (ENSC) has disclosed Debt Ratio for 3 consecutive years, with 0.02 as the latest value for Q4 2022.

  • On a quarterly basis, Debt Ratio fell 89.3% to 0.02 in Q4 2022 year-over-year; TTM through Dec 2022 was 0.02, a 89.3% decrease, with the full-year FY2022 number at 0.02, down 89.3% from a year prior.
  • Debt Ratio was 0.02 for Q4 2022 at Ensysce Biosciences, down from 0.27 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 1.61 in Q4 2020 to a low of 0.01 in Q1 2020.
  • A 3-year average of 0.24 and a median of 0.06 in 2020 define the central range for Debt Ratio.
  • Biggest YoY gain for Debt Ratio was 171.27% in 2022; the steepest drop was 89.3% in 2022.
  • Ensysce Biosciences' Debt Ratio stood at 1.61 in 2020, then tumbled by 86.18% to 0.22 in 2021, then plummeted by 89.3% to 0.02 in 2022.
  • Per Business Quant, the three most recent readings for ENSC's Debt Ratio are 0.02 (Q4 2022), 0.27 (Q3 2022), and 0.02 (Q2 2022).